Login / Signup

Cost-effectiveness of polymyxin B hemoperfusion for septic shock: an observational study using a Japanese nationwide administrative database.

Kenji FujimoriKunio TarasawaKiyohide Fushimi
Published in: Journal of Anesthesia, Analgesia and Critical Care (Online) (2023)
Polymyxin B hemoperfusion was shown to be an acceptable treatment in terms of the medical economy.
Keyphrases
  • septic shock
  • healthcare
  • cross sectional
  • gram negative
  • emergency department
  • adverse drug
  • smoking cessation